Vincent Peterkin

Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1

Mark E. Schnute, Matthew D. McReynolds, Tom Kasten et al. · Biochemical Journal · 2012 · 278 citations

Life Sciences, Cell Biology, Pharmacology +12

Limited influence of <i>UGT1A1*28</i> and no effect of <i>UGT2B7*2</i> polymorphisms on UGT1A1 or UGT2B7 activities and protein expression in human liver microsomes

Vincent Peterkin, Jonathan Bauman, Theunis C. Goosen et al. · British Journal of Clinical Pharmacology · 2007 · 56 citations · Full text

Life Sciences, Biochemistry, Genetics +13

A Humanized UGT1 Mouse Model Expressing the UGT1A1*28 Allele for Assessing Drug Clearance by UGT1A1-Dependent Glucuronidation

Hongliang Cai, Nghia Nguyen, Vincent Peterkin et al. · Drug Metabolism and Disposition · 2010 · 47 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

UDP-GLUCURONOSYLTRANSFERASE 2B7 IS THE MAJOR ENZYME RESPONSIBLE FOR GEMCABENE GLUCURONIDATION IN HUMAN LIVER MICROSOMES

Jonathan Bauman, Theunis C. Goosen, Meera Tugnait et al. · Drug Metabolism and Disposition · 2005 · 23 citations

Pharmacy, Pharmacokinetics, Pharmacology +10

A High Throughput, 384-Well, Semi-Automated, Hepatocyte Intrinsic Clearance Assay for Screening New Molecular Entities in Drug Discovery

Lance Heinle, Vincent Peterkin, Sonia de Morais et al. · Combinatorial Chemistry & High Throughput Screening · 2015 · 14 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17